当前位置： SCI文献检索 > Brachytherapy期刊下所有文献 > Is prostate-specific antigen percentage decrease predictive of clinical outcome after permanent iodine-125 interstitial brachytherapy for prostate cancer?

Is prostate-specific antigen percentage decrease predictive of clinical outcome after permanent iodine-125 interstitial brachytherapy for prostate cancer?

Abstract：

OBJECTIVE:To determine the usefulness of prostate-specific antigen (PSA) percentage (vs. pretreatment value assumed as 100%) in prediction of biochemical relapse, after iodine-125 ((125)I) permanent brachytherapy for prostate cancer, to employ a parameter independent by the initial PSA amount and by the individual prostatic volume. METHODS AND MATERIALS:Our study included 133 patients, 102 still disease free (Group A) and 31 who experienced proven biochemical recurrence (Group B). PSA levels before and after (125)I brachytherapy were recorded, and PSA percentage vs. pretreatment values were calculated. Cox regression model, receiver operating characteristic curves, and Kaplan-Meier regression model with log-rank test were calculated. RESULTS:We observed that, in patients submitted to brachytherapy for prostate cancer, a PSA percentage >20% of pretreatment value is highly associated with relapse risk (p<0.0001) and that this association is strongly present since t=6 months of followup (p<0.0001), with a hazard ratio near to five times (4.965), a sensitivity of 72.4%, and specificity of 79.8% related to the chosen cutoff. DISCUSSION:Despite the amount of PSA is the only parameter that the clinicians can deploy to monitor patient's followup after permanent interstitial brachytherapy for prostate cancer, its evolution in time seems unable to predict early biochemical relapse as it is influenced by prostatic volume and initial PSA amount. CONCLUSIONS:Our data suggest that a PSA percentage >20% of pretreatment value at 6 months might represent an early, inexpensive, and useful predictive tool of bad outcome in patients after permanent brachytherapy.

journal_name

Brachytherapy

journal_title

Brachytherapy

authors

Paoluzzi M,Mignogna M,Lorenzini E,Valent F,Fontana N,Pinzi N,Repetti F,Ponchietti R

doi

10.1016/j.brachy.2011.08.008

subject

Has Abstract

pub_date

2012-07-01 00:00:00

pages

277-83

issue

4

eissn

1538-4721

issn

1873-1449

pii

S1538-4721(11)00390-4

journal_volume

11

pub_type

杂志文章

相关文献

Brachytherapy文献大全
  • Is stereotactic CyberKnife radiotherapy or multicatheter HDR brachytherapy the better option dosimetrically for accelerated partial breast irradiation?

    abstract：OBJECTIVE:To compare dosimetrically the stereotactic CyberKnife (CK) therapy and multicatheter high-dose-rate (HDR) brachytherapy (BT) for accelerated partial breast irradiation (APBI). METHODS:Treatment plans of 25 patients treated with CK were selected, and additional plans using multicatheter HDR BT were created on...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2020.10.003

    authors： Fröhlich G,Mészáros N,Smanykó V,Stelczer G,Herein A,Polgár C,Major T

    更新日期：2020-11-18 00:00:00

  • Clinical feasibility of interstitial brachytherapy using a "hybrid" applicator combining uterine tandem and interstitial metal needles based on CT for locally advanced cervical cancer.

    abstract：PURPOSE:To explore the dosimetric advantage of target volume and surrounding normal tissue by using interstitial (IS) brachytherapy (BT) based on three-dimensional CT in locally advanced cervical cancer, as a simple and effective clinical treatment approach. METHODS AND MATERIALS:Fifty-two patients with poor tumor res...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2016.06.004

    authors： Liu ZS,Guo J,Lin X,Wang HY,Qiu L,Ren XJ,Li YF,Zhang BY,Wang TJ

    更新日期：2016-09-01 00:00:00

  • Minimal channel GreenLight photovaporization before permanent implant prostate brachytherapy for patients with obstructive symptoms: Technically feasible and safe.

    abstract：PURPOSE:Brachytherapy (BrT) is a standard treatment for low-risk to favorable-intermediate-risk prostate cancer but is a relative contraindication for patients with obstructive symptoms. We aimed to assess the feasibility and urinary toxicity of a minimal photovaporization (mPVP) before implantation. MATERIALS AND MET...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2020.08.003

    authors： Peigne C,Fournier G,Dissaux G,Delage F,Coquet JB,Boussion N,Goasduff G,Malhaire JP,Pradier O,Schick U,Valeri A

    更新日期：2021-01-01 00:00:00

  • Prostate-specific antigen bounce after curative brachytherapy for early-stage prostate cancer: A study of 274 African-Caribbean patients.

    abstract：BACKGROUND:Prostate cancer incidence in the African-Caribbean population ranks among the highest worldwide. We aim to evaluate the prostate-specific antigen (PSA) kinetics after brachytherapy, which so far remains unknown in this population. METHODS AND MATERIALS:From 2005 to 2013, 371 patients received (125)I brachyt...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2015.09.005

    authors： Leduc N,Atallah V,Creoff M,Rabia N,Taouil T,Escarmant P,Vinh-Hung V

    更新日期：2015-11-01 00:00:00

  • High-dose-rate interstitial brachytherapy for previously untreated cervical carcinoma.

    abstract：PURPOSE:The aim of the study was to evaluate the results of high-dose-rate interstitial brachytherapy (HDR-ISBT) for patients with advanced cervical carcinoma in which intracavitary radiation therapy may result in a suboptimal dose distribution. METHODS AND MATERIALS:Between 1995 and 2005, 25 patients of median age 64...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2008.12.002

    authors： Isohashi F,Yoshioka Y,Koizumi M,Konishi K,Sumida I,Takahashi Y,Ogata T,Morishige KI,Enomoto T,Kawaguchi Y,Kotsuma T,Adachi K,Fukuda S,Akino Y,Inoue T

    更新日期：2009-04-01 00:00:00

  • Unusually high prostate-specific antigen bounce after prostate brachytherapy: Searching for etiologic factors.

    abstract：PURPOSE:Determine whether fat distribution, body mass index, or clinical and dosimetric factors are associated with prostate specific antigen (PSA) bounce (PSAb) of ≥1.6 ng/mL in patients treated with permanent seed (125)I prostate brachytherapy (PB). METHODS AND MATERIALS:We identified 23 patients with a PSAb of ≥1.6...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2013.05.005

    authors： Chira C,Taussky D,Gruszczynski N,Meissner A,Larrivée S,Carrier JF,Donath D,Delouya G

    更新日期：2013-11-01 00:00:00

  • Income generated by women treated with magnetic resonance imaging-based brachytherapy: A simulation study evaluating the macroeconomic benefits of implementing a high-end technology in a public sector healthcare setting.

    abstract：PURPOSE:To estimate the difference in income generated if all women presenting in our institute over a 5-year period were treated with MRI-based image-guided brachytherapy (MR-IGBT) instead of conventional radiograph-based brachytherapy (CR-BT). METHODS AND MATERIALS:Outcome data from 463 patients (94 treated with MR-...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2017.05.003

    authors： Chakraborty S,Mahantshetty U,Chopra S,Lewis S,Hande V,Gudi S,Krishnatry R,Engineer R,Shrivastava SK

    更新日期：2017-01-01 00:00:00

  • Evaluating the influence of prostate-specific antigen kinetics on metastasis in men with PSA recurrence after partial gland therapy.

    abstract：PURPOSE:Although current Delphi Consensus guidelines do not recommend a specific definition of biochemical recurrence after partial gland therapy, these guidelines acknowledge that serial prostate-specific antigen (PSA) tests remain the best marker for monitoring disease after treatment. The purpose of this study was t...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2018.12.001

    authors： King MT,Nguyen PL,Boldbaatar N,Yang DD,Muralidhar V,Tempany CM,Cormack RA,Hurwitz MD,Suh WW,Pomerantz MM,D'Amico AV,Orio PF 3rd

    更新日期：2019-01-01 00:00:00

  • Clinical outcomes using image-guided interstitial brachytherapy for definitive cervical cancer patients with high-risk clinical target volumes greater than 30 cc.

    abstract：PURPOSE:Given the limited data using an interstitial approach with 3D-based planning for definitive cervical cancer utilizing the GEC-ESTRO defined high-risk clinical target volume (HR-CTV), we reviewed our institutional experience of cervical cancer patients with HR-CTVs ≥ 30 cc to determine whether our clinical and t...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2017.10.004

    authors： Wang C,Raince J,Swamy U,Park SJ,Zaide L,Mesko S,Demanes DJ,Kamrava M

    更新日期：2018-01-01 00:00:00

  • Frequency of whole breast radiation therapy after intraoperative radiation therapy due to criteria identified by lumpectomy.

    abstract：PURPOSE:For selected early breast cancers, intraoperative radiation therapy (IORT) at the time of lumpectomy can be an efficient alternative to fractionated whole breast radiation therapy (WBRT). However, some patients are later recommended WBRT after IORT due to surgical pathologic findings. To understand risk factor ...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2016.09.012

    authors： Mellon EA,Orman A,Joya LE,Montejo ME,Laronga C,Hoover SJ,Lee MC,Khakpour N,Kubal PF,Diaz R

    更新日期：2017-01-01 00:00:00

  • Clinical outcomes of high-dose-rate brachytherapy and external beam radiotherapy in the management of clinically localized prostate cancer.

    abstract：PURPOSE:To report prostate-specific antigen (PSA) relapse-free survival and treatment-related toxicity outcomes after combining high-dose-rate (HDR) brachytherapy with external beam radiotherapy (EBRT) for patients with clinically localized prostate cancer. METHODS AND MATERIALS:Between 1998 and 2009, 229 patients wer...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2012.05.003

    authors： Kotecha R,Yamada Y,Pei X,Kollmeier MA,Cox B,Cohen GN,Zaider M,Zelefsky MJ

    更新日期：2013-01-01 00:00:00

  • Process improvement for the safe delivery of multidisciplinary-executed treatments-A case in Y-90 microspheres therapy.

    abstract：PURPOSE:To develop a safe and robust workflow for yttrium-90 (Y-90) radioembolization procedures in a multidisciplinary team environment. METHODS AND MATERIALS:A generalized Define-Measure-Analyze-Improve-Control (DMAIC)-based approach to process improvement was applied to a Y-90 radioembolization workflow. In the fir...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2016.08.001

    authors： Cai B,Altman MB,Garcia-Ramirez J,LaBrash J,Goddu SM,Mutic S,Parikh PJ,Olsen JR,Saad N,Zoberi JE

    更新日期：2017-01-01 00:00:00

  • Phase I-II trial of perioperative high-dose-rate brachytherapy in oral cavity and oropharyngeal cancer.

    abstract：BACKGROUND:To determine the feasibility of combined perioperative high-dose-rate brachytherapy (PHDRB) and intermediate-dose external beam radiation therapy (EBRT) as an alternative to full-dose adjuvant EBRT in patients with unirradiated squamous cell cancer (SCC) of the oral cavity and oropharynx. METHODS AND MATERI...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2008.10.002

    authors： Martínez-Monge R,Gómez-Iturriaga A,Cambeiro M,Garrán C,Montesdeoca N,Aristu JJ,Alcalde J

    更新日期：2009-01-01 00:00:00

  • Trends in the utilization of adjuvant vaginal brachytherapy in women with early-stage endometrial carcinoma: Results of an updated period analysis of SEER data.

    abstract：PURPOSE:Adjuvant vaginal brachytherapy (VB) is a well-established and effective radiation treatment modality in women with early-stage endometrial carcinoma. We sought to evaluate and update published trends in the utilization of VB vs. other radiation therapy modalities (pelvic external beam radiation therapy (EBRT) o...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2016.06.012

    authors： Modh A,Ghanem AI,Burmeister C,Rasool N,Elshaikh MA

    更新日期：2016-09-01 00:00:00

  • A new short daily brachytherapy schedule in postoperative endometrial carcinoma. Preliminary results.

    abstract：PURPOSE:To evaluate the preliminary results of vaginal-cuff relapses (VCR) and complications of a short brachytherapy (BT) schedule in postoperative endometrial carcinoma. METHODS AND MATERIALS:From September 2011 to December 2014, 102 patients were treated with postoperative BT for endometrial carcinoma. Seventy-four...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2016.10.001

    authors： Rovirosa Á,Ascaso C,Herreros A,Sánchez J,Holub K,Camarasa A,Sabater S,Oses G,García-Miguel J,Rivera Y,Arenas M

    更新日期：2017-01-01 00:00:00

  • Novel and programmatic improvements to the workflow associated with the AccuBoost breast brachytherapy procedure.

    abstract：PURPOSE:While the noninvasive breast brachytherapy (NIBB) treatment procedure, known as AccuBoost, for breast cancer patients is well established, the treatment quality can be improved by the efficiency of the workflow delivery. A formalized approach evaluated the current workflow through failure modes and effects anal...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2020.01.007

    authors： Roles SA,Hepel JT,Leonard KL,Wazer DE,Cardarelli GA,Schwer ML,Saleh ZH,Klein EE,Brindle JM,Rivard MJ

    更新日期：2020-01-01 00:00:00

  • Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecologic cancer: Initial results of a phase II trial.

    abstract：BACKGROUND:This study was undertaken to determine the feasibility of perioperative high-dose-rate brachytherapy (PHDRB) as an adjunct to salvage surgery in primary advanced or recurrent gynecologic cancer. METHODS:Twenty-five patients with either locally advanced (n = 4) or recurrent (n = 21) gynecologic cancer suitab...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2006.07.001

    authors： Martínez-Monge R,Jurado M,Cambeiro M,Valero J,Villafranca E,Alcázar JL

    更新日期：2006-10-01 00:00:00

  • Salvage high-dose-rate brachytherapy for esophageal cancer in previously irradiated patients: A retrospective analysis.

    abstract：PURPOSE:To evaluate outcomes after exclusive salvage high-dose-rate (HDR) intraluminal esophageal brachytherapy given to previously irradiated patients with recurrent esophageal cancer. METHODS AND MATERIALS:We reviewed medical records of 30 patients who were treated by salvage HDR brachytherapy for local esophageal c...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2015.02.392

    authors： Wong Hee Kam S,Rivera S,Hennequin C,Lourenço N,Chirica M,Munoz-Bongrand N,Gornet JM,Quéro L

    更新日期：2015-07-01 00:00:00

  • A detailed examination of the difference between planned and treated margins in 125I permanent prostate brachytherapy.

    abstract：PURPOSE:To determine whether potential extraprostatic extension (EPE) of prostate adenocarcinoma is covered by the prescribed dose when permanent 125I implants are planned with a 5-mm treatment margin. METHODS AND MATERIALS:The postimplant dosimetry of 60 consecutive 125I prostate implants was analyzed to determine wh...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2003.09.002

    authors： Patel AB,Waterman FM,Dicker AP

    更新日期：2003-01-01 00:00:00

  • Salvage wide resection with intraoperative electron beam therapy or HDR brachytherapy in the management of isolated local recurrences of soft tissue sarcomas of the extremities and the superficial trunk.

    abstract：PURPOSE:To assess the toxicity and efficacy of salvage wide resection (SWR) with intraoperative electron beam radiation therapy (IOERT) or perioperative high-dose-rate brachytherapy (PHDRB) in previously unirradiated patients (PUP) vs. previously irradiated patients (PIP) with isolated local recurrence of soft tissue s...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2014.09.003

    authors： Cambeiro M,Aristu JJ,Moreno Jimenez M,Arbea L,Ramos L,San Julian M,Azinovic I,Calvo FA,Martínez-Monge R

    更新日期：2015-01-01 00:00:00

  • Feasibility and full-course dosimetry of an intraoperatively placed multichannel brachytherapy catheter for accelerated partial breast irradiation.

    abstract：PURPOSE:Determine feasibility and resultant dosimetry of an intraoperatively placed multichannel intracavitary brachytherapy catheter for accelerated partial breast irradiation (APBI). METHODS:Patients with breast cancer underwent intraoperative brachytherapy catheter placement based on frozen section analysis with im...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2016.08.002

    authors： Stish BJ,Pafundi DH,Hieken TJ,Whitaker TJ,Furutani KM,Jakub JW,Boughey JC,Degnim AC,McLemore LB,Mou B,Mutter RW,Park SS

    更新日期：2016-01-01 00:00:00

  • Toward a dynamic real-time intraoperative permanent prostate brachytherapy methodology.

    abstract：PURPOSE:To evaluate dosimetry and source location relative to CT-based dosimetry when performing real-time dynamic permanent prostate brachytherapy (PPB) with inverse treatment planning. METHODS AND MATERIALS:A treatment algorithm for dynamic PPB was developed using inverse treatment planning. The technique utilizes r...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/S1538-4721(03)00134-X

    authors： Potters L,Calguaru E,Thornton KB,Jackson T,Huang D

    更新日期：2003-01-01 00:00:00

  • Substantial lymphovascular space invasion predicts worse outcomes in early-stage endometrioid endometrial cancer.

    abstract：INTRODUCTION:Substantial as opposed to focal or no lymphovascular space invasion (LVSI) is proposed as an independent adverse prognostic factor in patients with early-stage endometrioid endometrial cancer (EEC). We reviewed outcomes of patients treated with adjuvant vaginal brachytherapy (VB) alone in a single institut...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2020.12.006

    authors： Barnes EA,Martell K,Parra-Herran C,Taggar AS,Donovan E,Leung E

    更新日期：2021-01-20 00:00:00

  • Improved survival for patients with prostate cancer receiving high-dose-rate brachytherapy boost to EBRT compared with EBRT alone.

    abstract：PURPOSE:High-dose-rate (HDR) brachytherapy boost is a treatment of intermediate- to high-risk prostate cancer, but long-term clinical outcome data are sparse. We report long-term survival and toxicity data in a cohort of patients treated in a single institution. METHODS:Between 1998 and 2004, 654 patients with localiz...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2019.01.013

    authors： Kent AR,Matheson B,Millar JL

    更新日期：2019-01-01 00:00:00

  • A comparative dosimetric analysis of virtual stereotactic body radiotherapy to high-dose-rate monotherapy for intermediate-risk prostate cancer.

    abstract：PURPOSE:Stereotactic body radiotherapy (SBRT) is being used with increasing frequency as definitive treatment of early stage prostate cancer. Much of the justification for its adoption was derived from earlier clinical results using high-dose-rate (HDR) brachytherapy. We determine whether HDR's dosimetry can be achieve...

    journal_title：Brachytherapy

    pub_type： 临床试验,杂志文章

    doi：10.1016/j.brachy.2013.03.003

    authors： Spratt DE,Scala LM,Folkert M,Voros L,Cohen GN,Happersett L,Katsoulakis E,Zelefsky MJ,Kollmeier MA,Yamada Y

    更新日期：2013-09-01 00:00:00

  • Interstitial brachytherapy in the management of persistent head and neck disease after definitive external beam radiation therapy.

    abstract：PURPOSE:Persistent disease after definitive external beam radiation therapy for head and neck (H&N) malignancies negatively impacts survival. In this series, the effectiveness of low-dose-rate brachytherapy in the management of persistent H&N disease is explored. METHODS:All patients who received brachytherapy for per...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2008.12.007

    authors： Grimard L,Esche B,Lamothe A,Spaans JN

    更新日期：2009-07-01 00:00:00

  • Validation of a radiobiological model for low-dose-rate prostate boost focal therapy treatment planning.

    abstract：PURPOSE:Low-dose-rate brachytherapy using iodine-125 seeds is a highly efficacious treatment for low-risk prostate cancer. We propose a bioeffect model may be used to target an ablative dose to the tumor with a lower, therapeutic dose to low-risk regions to maintain high rates of tumor control with reduced toxicity. We...

    journal_title：Brachytherapy

    pub_type： 杂志文章,多中心研究

    doi：10.1016/j.brachy.2013.04.008

    authors： Haworth A,Williams S,Reynolds H,Waterhouse D,Duchesne GM,Bucci J,Joseph D,Bydder S,Ebert M

    更新日期：2013-11-01 00:00:00

  • The effect of isotope selection on the prostate-specific antigen response in patients treated with permanent prostate brachytherapy.

    abstract：PURPOSE:To assess the difference in prostate-specific antigen (PSA) response kinetics in patients undergoing either (125)I or (103)Pd permanent prostate brachytherapy (PPB). METHODS AND MATERIALS:Between 1997 and 1999, 333 patients underwent PPB as monotherapy. Forty-eight patients received a (125)I implant, and 285 r...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/S1538-4721(03)00004-7

    authors： Potters L,Huang D,Fearn P,Kattan MW

    更新日期：2003-01-01 00:00:00

  • Dose homogeneity analysis of adjuvant radiation treatment in surgically resected brain metastases: Comparison of IORT, SRS, and IMRT indices.

    abstract：PURPOSE:Although surgery remains a treatment option for symptomatic brain metastases, the need for adjuvant radiation after surgery is widely accepted as standard. Despite a multitude of randomized trials aimed at identifying the ideal radiation treatment plan for surgically resected metastases, the development of new ...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2020.11.004

    authors： Dahshan BA,Weir JS,Bice RP,Renz P,Cifarelli DT,Poplawski L,Hack J,Vargo JA,Cifarelli CP

    更新日期：2021-01-13 00:00:00

  • Clinical use of magnetic resonance imaging across the prostate brachytherapy workflow.

    abstract：:MRI produces better soft tissue contrast than does ultrasonography or computed tomography for visualizing male pelvic anatomy and prostate cancer. Better visualization of the tumor and organs at risk could allow better conformation of the dose to the target volumes while at the same time minimizing the dose to critica...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2016.11.012

    authors： Blanchard P,Ménard C,Frank SJ

    更新日期：2017-01-01 00:00:00